Malignancies metastatic to the larynx are rare, accounting for fewer than 1% of all laryngeal cancers with metastatic sources; the most common of these metastases are cutaneous melanomas and renal cell carcinomas. Only 13 cases of colon cancer and 2 cases of rectal adenocarcinoma metastatic to the larynx have been previously reported in the literature. We report a new case of rectal adenocarcinoma metastatic to the larynx that resulted in subglottic stenosis in a 60-year-old man. We also review the literature, and we discuss the presentations of and treatments for this rare entity.
Introduction
Metastatic disease to the larynx is rare, accounting for only 0.09 to 0.40% of all laryngeal tumors. 1 Th e most common sites of primary malignancies metastatic to the larynx are the skin (melanoma) and the kidney (renal cell carcinoma); other primary sites include the breast, lung, prostate, stomach, and ovaries. 1, 2 Metastasis of a rectal adenocarcinoma to the larynx is extremely rare. To the best of our knowledge, only 2 such cases have been previously reported in the literature (table) . 3, 4 In 1998, Hilger et al described a case of rectal adenocarcinoma that had metastasized to the subglottis and was treated with tracheostomy and laryngectomy. 3 In 2007, Ramanathan et al reported a case in which a rectal metastasis to the laryngeal ventricle destroyed parts of the thyroid and hyoid cartilages. 4 In addition to rectal carcinoma, 13 cases of colon cancer metastatic to the larynx can be found in literature. Most cases of metastatic colorectal cancer have involved the lung, liver, bone, and brain.
Th e rarity of distant metastases to the larynx, regardless of the site of the primary, has been attributed to the organ's location at the terminus of the lymphatic and vascular circulation systems. 5 When the larynx is involved, common subsites are the supraglottis and subglottis because the lymphatic and blood systems in those sites are well developed.
In this article, we report a new, aggressive case of rectal adenocarcinoma metastatic to the larynx, and we review the presentations of and treatments for colorectal primaries metastatic to the larynx.
Case report
A 60-year-old black man with a remote history of smoking presented with worsening dyspnea on exertion, progression to persistent audible breathing at rest of 6 months' duration, and dysphonia. Four years earlier, the patient had undergone a colonoscopy, which detected multiple colonic polyps and a 40-mm mass in the distal rectum 2 cm from the anal verge. He was diagnosed with stage IIA, category T3N0M0, grade 3 adenocarcinoma of the rectum and treated with 5-fl uorouracil (5-FU) chemotherapy and 45 Gy of radiotherapy. Four months later, he underwent abdominoperineal resection with colostomy placement. Pathology identifi ed his disease as an infi ltrating, moderately diff erentiated adenocarcinoma with regional nodal spread, and it was reclassifi ed as stage IIIA, category T2N1M0, grade 3. Postoperatively, he received further chemotherapy with capecitabine. Two years aft er surgery, multiple bilateral lung nodules were discovered. Biopsy revealed that these lesions represented distant metastases of his rectal cancer. Th e patient chose to undergo multiple systemic chemotherapeutic regimens that included, alone or in combination, leucovorin, 5-FU, irinotecan, bevacizumab, and pegfi lgrastim.
During the patient's initial examination at our otolaryngology clinic, fl exible laryngoscopy detected a signifi cant subglottic narrowing with mobile true vocal metastatic rectal adenocarcinoma, with positivity for CK20 and negativity for CK7 (fi gure 3).
Th e patient's recovery was uneventful, and his dyspnea abated signifi cantly. Subsequent postoperative clinic visits showed reestablishment of the subglottic stenosis folds (fi gure 1). In addition, a fi rm left supraclavicular adenopathy measuring 2.0 cm was discovered. Computed tomography (CT) confirmed the subglottic mass and the subglottic narrowing to 5 mm in the axial plane (fi gure 2). Th e mass was circumferentially calcifi ed, and the cricoid cartilage and upper tracheal rings had a "moth-eaten" appearance. Th e patient was urgently scheduled for an awake tracheostomy along with bronchoscopy and suspension microlaryngoscopy for biopsy and debulking of the mass. Th e debulking was performed submucosally, and closure was achieved with a microfl ap. Th e airway was reestablished with 40% lumen patency. Pathology fi ndings were consistent with to only 15% lumen patency over a period of 4 weeks, but the tracheostomy was functioning well and the patient demonstrated good exercise tolerance. He was able to vocalize well with a Passy-Muir valve. He restarted his chemotherapy with 5-FU and irinotecan.
Discussion
Metastatic spread can occur via the hematogenous and lymphatic routes. Th e route for hematogenous spread via the systemic circulation is the inferior vena cava, right heart, lungs, left heart, aorta, external carotid artery, upper thyroid artery, and upper laryngeal artery. 6 Th e vertebral venous plexus has also been implicated in retrograde metastatic spread of colorectal carcinoma. 7 Lymphatic metastases spread via the thoracic duct, left supraclavicular lymph nodes, and subglottic lymph nodes. 8 Our patient had both a subglottic metastasis and left neck lymphadenopathy, a fi nding that supports both a hematogenous and lymphatic route of spread of his rectal adenocarcinoma to the larynx. Furthermore, it is possible that the metastasis to the cricoid cartilage or to the inferior aspect of the thyroid cartilage represented the initial location of the metastasis. Th e laryngeal cartilages undergo endochondral ossifi cation in adulthood, with possible bone marrow formation that can harbor metastatic disease. 9 Th is possibility is supported by the moth-eaten appearance of the erosion of the calcifi ed cricoid cartilage.
Our review of the literature reveals that the mean age of patients who have presented with laryngeal metastasis of a colorectal primary was 67.5 years (median: 67.0; range: 51 to 83). Th e 16 reported cases have involved 9 women, 6 men, and 1 patient whose sex was not reported. Th e primary source of the metastasis was the sigmoid colon in 4 cases, the right colon in 3 cases, the rectum in 3 cases (including our patient), the cecum in 1 case, and an unspecifi ed colonic location in 5 cases. Data on presenting symptoms are available for 15 of the 16 patients; 9 (60%) presented with dyspnea on exertion, 9 with dysphonia, 3 (20%) with stridor, and 1 each (7%) with otalgia and a globus sensation. Data on laryngeal subsites of metastasis are available for 14 patients; the most common subsite was the subglottis (n = 7 [50%]), followed by the transglottis (n = 3 [21%]), supraglottis (n = 2 [14%]), and glottis (n = 1 [7%]). Data on other sites of distant metastasis are available on 14 patients; 12 had other sites of distant metastasis, and the other 2 had an isolated laryngeal metastasis. Of the 12 patients with other sites of distant metastasis, lung metastasis was present in 7 and liver metastasis in 5. Other sites of concomitant distant metastasis included the mediastinum, peritoneum, bone, and thyroid.
In view of the rare nature of this presentation, management guidelines are nonexistent and treatment has been by necessity individualized. However, a general recommendation can be made that symptomatic and palliative treatment should be administered to patients with multiple metastases, including the larynx. Intervention options include bronchoscopy, direct laryngoscopy with laser excision, and debulking of the laryngeal mass. Tracheostomy can be performed in patients with signifi cant respiratory distress from airway obstruction. A reasonable chance of curative treatment can be expected only for those patients with a solitary laryngeal metastasis, and some long-term survival in such cases has been recorded in the literature. 2 Curative interventions range from endoscopic resection to total laryngectomy, depending on the location and size of the metastatic tumor, but overall, the prognosis for patients with laryngeal metastasis is poor because laryngeal in- volvement generally has been seen in terminal patients with other multiple metastases.
Our case was a rare presentation of metastatic rectal adenocarcinoma. However, it is possible that the actual clinical prevalence of distant metastasis to the larynx has been underestimated. Friedmann and Osborn reported that 23.9% of patients with metastasis to the head and neck had laryngeal and tracheal diseases on autopsy. 10 With this possibility in mind, clinicians should include laryngeal or subglottic metastasis in the diff erential diagnosis of a patient with a history of colorectal adenocarcinoma who presents with dyspnea, dysphonia, stridor, globus, and/or otalgia.
